New antivirals give experts hope of curing HCV

11/4/2013 | Nature (free content)

Experts say new oral antiviral therapies, some awaiting regulatory approval and others still in clinical trials, show eradicating hepatitis C worldwide may be possible given the characteristics of the disease. However, drug-resistant strains, the high cost of the drugs and silent carriers continue to pose challenges, experts say.

View Full Article in:

Nature (free content)

Published in Briefs: